AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MICROSAIC SYSTEMS PLC

Board/Management Information May 16, 2019

7786_rns_2019-05-16_6c109031-2ff1-4f6c-8d31-fb93113a4312.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3044Z

Microsaic Systems plc

16 May 2019

16 May 2019

Microsaic Systems plc 

("Microsaic", "Microsaic Systems" or the "Company")

Board Change

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, following the announcement on 11 March 2019 at the time of the Company's final results, announces that Professor Andrew Holmes, Non-Executive Director and Company Secretary, has stepped down from the Board with immediate effect.

The Board thanks Andrew for his dedication and support to the Company over the last 18 years. Bevan Metcalf, Finance Director, has taken on the additional responsibilities of Company Secretary.

Enquiries:
Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD & Company Secretary
+44 (0) 1483 751 577
N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson (Corporate Finance)

Tom Salvesen (Corporate Broking)
+44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler
+44 (0)20 3934 6630

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAAFMJTMBMBBAL

Talk to a Data Expert

Have a question? We'll get back to you promptly.